Skip to main content
TipRanks
Go Ultimate75% OFF

Michael D. West Insider Profile

4 Followers

Michael D. West, CEO at Serina Therapeutics, holds 41.98K shares in Serina Therapeutics (Ticker: SER), holds 893.91K shares in Lineage Therap (Ticker: LCTX), holds 0.00 shares in Asterias Biotherapeutics (Ticker: AST).

Michael D. West's Trading History

SER
Serina Therapeutics
Mar 14, 2023CEOUninformative Buy1.22K$58.35K
LCTX
Lineage Therap
Sep 19, 2018Co- CEO, DirectorUninformative Buy16.53K$817.04K
OCAT
Ocata Therapeutics
―――$57.69M
AST
Asterias Biotherapeutics
―――$0.00

You May Also Like

Michael D. West insider profile FAQ

What is the percentage of profitable transactions made by Michael D. West?
The percentage of profitable transactions made by Michael D. West is 33%.
What is the average return per transaction made by Michael D. West?
The average return per transaction made by Michael D. West is 4.40%.
What stocks does Michael D. West hold?
Michael D. West holds: SER, LCTX, AST, OCAT stocks.
What was Michael D. West’s latest transaction?
Michael D. West’s latest transaction was an Uninformative Buy of $1.22K.
What was Michael D. West's most profitable transaction?
Michael D. West’s most profitable transaction was an Informative Buy of LCTX stock on July 23, 2014. The return on the trade was 18.50%.
What is Michael D. West's role in Serina Therapeutics?
Michael D. West's role in Serina Therapeutics is CEO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.